A population-based study of the drug interaction between proton pump inhibitors and clopidogrel - Wikidata - awgldk - TriplyDB

A population-based study of the drug interaction between proton pump inhibitors and clopidogrel

A population-based study of the drug interaction between proton pump inhibitors and clopidogrel

http://www.wikidata.org/entity/Q34603772

about

Antiplatelet resistance in stroke Impact of proton pump inhibitors on efficacy of clopidogrel: Review of evidence Clopidogrel and interaction with proton pump inhibitors: comparison between cohort and within person study designs The drug-drug interaction between proton pump inhibitors and clopidogrel Diagnosis and therapy of non-variceal upper gastrointestinal bleeding Clopidogrel and proton pump inhibitors--where do we stand in 2012?Current perspectives in NSAID-induced gastropathy Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy Pharmacokinetic drug interaction profiles of proton pump inhibitors: an update What is the optimum prophylaxis against gastrointestinal haemorrhage for patients undergoing adult cardiac surgery: histamine receptor antagonists, or proton-pump inhibitors?Potential drug-drug interactions in prescriptions to patients over 45 years of age in primary care, southern Brazil Proton pump inhibitors and hospitalization with hypomagnesemia: a population-based case-control study Effects of Clopidogrel and Proton Pump Inhibitors on Cardiovascular Events in Patients with Type 2 Diabetes Mellitus after Drug-Eluting Stent Implantation: A Nationwide Cohort Study Impact of proton pump inhibitor therapy on the efficacy of clopidogrel in the CAPRIE and CREDO trials.Clopidogrel: the data, the experience, and the controversies.Recent advances in antithrombotic therapy after acute coronary syndrome.Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study Cardiovascular outcomes and mortality in patients using clopidogrel with proton pump inhibitors after percutaneous coronary intervention or acute coronary syndrome The risk of endoscopic mucosal resection in the setting of clopidogrel use.Clopidogrel and proton pump inhibitors: a new drug interaction?Modern role for clopidogrel in management of atrial fibrillation and stroke reduction The potential interaction between clopidogrel and proton pump inhibitors: a systematic review.The impact of treatment with omeprazole on the effectiveness of clopidogrel drug therapy during the first year after successful coronary stenting Pantoprazole Does Not Reduce the Antiplatelet Effect of Clopidogrel: A Randomized Controlled Trial in Korea Antiplatelet drug interactions with proton pump inhibitors Implementing genotype-guided antithrombotic therapy.Privacy-maintaining propensity score-based pooling of multiple databases applied to a study of biologics.Influences of different proton pump inhibitors on the anti-platelet function of clopidogrel in relation to CYP2C19 genotypes Effects of drug interactions on biotransformation and antiplatelet effect of clopidogrel in vitro.Clinical importance of aspirin and clopidogrel resistance Incidence of cardiovascular events and gastrointestinal bleeding in patients receiving clopidogrel with and without proton pump inhibitors: an updated meta-analysis The risk of hypotension following co-prescription of macrolide antibiotics and calcium-channel blockers Effect of proton pump inhibitors on the serum concentrations of the selective serotonin reuptake inhibitors citalopram, escitalopram, and sertraline Drug-drug interaction between clopidogrel and the proton pump inhibitors.Risk management of risk management: Combining proton pump inhibitors with low-dose aspirin Clinical evidence of interaction between clopidogrel and proton pump inhibitors The safety of drugs used in acid-related disorders and functional gastrointestinal disorders.Effect of proton pump inhibitors on platelet inhibition activity of clopidogrel in Chinese patients with percutaneous coronary intervention Prognosis of concomitant users of clopidogrel and proton-pump inhibitors in a high-risk population for upper gastrointestinal bleeding.Comparative pharmacokinetics of cyclophosphamide administration alone and combination with vitamin B6 in rats.

P2860

Q22305927-EE6733B2-085A-4633-9E3B-EBDF6EA3CAD1 Q24608981-93EF8C1B-02F2-4BC4-BF4D-D24E4F94C037 Q24633087-73CF1924-28D0-409A-9F89-6E437306A6F0 Q24653812-589991C3-908A-4989-9BC7-0B243391F813 Q26777626-AED30284-D1A0-432C-A142-4946FBD9E425 Q26825728-DD6D9861-53F0-4D42-88CE-474E4ED56697 Q26827673-522DC957-617B-4128-94DD-1C11B2188092 Q26998331-624ED13D-5BD6-459E-BDAE-EB3F623F6A76 Q27022254-3C40E088-AF2F-4A0F-A523-539C3F27C38C Q27025253-B01A6139-275A-4C21-936D-48464351FD06 Q28484317-E212F625-4962-47E7-AA99-5373EC63E779 Q28543390-FCA5AFC6-CE58-4BB7-8C2C-D5A934EE3173 Q28547539-8994B16D-E8D4-4E7E-9341-1D239BBF14E2 Q30421742-09129E2B-6A8A-4750-B43A-8790B246AF1F Q30573045-A52876E0-8C87-4A49-9248-E81A3DB7017B Q33590548-F52BCB62-02E4-4409-AD8F-A97B83E6B0C6 Q33634928-B2EEA5FA-E0BA-4B42-9C41-13CB373C9504 Q33639452-4CBD53EF-52DC-4DD8-BFEE-D7399115A39E Q33692737-288129DA-2CA9-4EDD-A9F6-7623169F66F9 Q33705305-47C9092F-89AB-41BA-B081-3F219FF46461 Q33715413-E22717D0-C6EB-4D51-9DE9-AD7FF13C8C03 Q33763929-6CB49232-D00A-4320-80E8-B98C3CF6D2D7 Q33776115-B97D20D3-3D72-467B-9D0F-22D3ABB99619 Q33853179-B2E42578-987E-4752-84F6-1E314914ADA5 Q33948811-C3F56A84-8A63-4DD0-AE12-09A3BADF40D1 Q33990428-5E8C2A16-AFF1-4F3B-A653-84564C2F46E6 Q34104550-D5DCAAEA-A102-43B7-9040-4EED8720F8EE Q34174915-9BBED11E-21D5-4E50-9817-7E0360F12304 Q34339780-E1372053-65C6-4158-B2B1-CCF1E2DFC892 Q34390050-B78C8F7B-9CA5-4FF5-BC08-2FD16A68C7DB Q34486149-A911D429-2511-48DE-BB8E-C2B0664B761C Q34589838-FF3C4B25-B361-4DF5-96F4-E796226E1821 Q34978292-CE1592DC-0126-4D77-A0F8-CC61EC43FCC3 Q34983154-8155C21D-465B-4DA5-8EBD-EC78EFD52386 Q35026472-B2B67AEE-CB30-449D-82FE-040E4DF124D3 Q35033722-11E039AA-8731-4331-8BC7-1B6AF885434E Q35052602-ABF8DC65-BBEF-4D9A-B458-0A13E9D1DD8C Q35122933-0B796F09-CCC8-47C4-A3D5-2F9F21E26D24 Q35147463-35A0FBD0-6EBD-4B18-95E7-DA0745A4EFA5 Q35166504-211B221F-97CF-4C59-B219-7CA5BB5276CD

P2860

A population-based study of the drug interaction between proton pump inhibitors and clopidogrel

http://www.wikidata.org/entity/Q34603772

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

A population-based study of th ...... ump inhibitors and clopidogrel

@ast

A population-based study of th ...... ump inhibitors and clopidogrel

@en

A population-based study of th ...... ump inhibitors and clopidogrel

@nl

type

label

A population-based study of th ...... ump inhibitors and clopidogrel

@ast

A population-based study of th ...... ump inhibitors and clopidogrel

@en

A population-based study of th ...... ump inhibitors and clopidogrel

@nl

prefLabel

A population-based study of th ...... ump inhibitors and clopidogrel

@ast

A population-based study of th ...... ump inhibitors and clopidogrel

@en

A population-based study of th ...... ump inhibitors and clopidogrel

@nl

P1433

Q34603772-3B413A6F-35CD-410F-8C62-5FFBBDE4D413

P1476

Q34603772-2EF49E74-E273-4A3C-8621-EE0514DB71A3

P2093

Q34603772-087B2FEC-D3F8-46B3-B82D-8AB22BAFC5E7

Q34603772-2FE625F8-3F01-4BB4-B7A3-042301292EC6

Q34603772-37E2A8CF-B0E5-4DE4-A354-6FEA4E02EAD8

Q34603772-41755D16-7DA5-4876-9E88-9F839A3EE571

Q34603772-79295FC8-676A-47A1-990C-3D3B3DBC2600

P2860

Q34603772-0A5094A7-9540-4D1F-928A-F24CB1154671

Q34603772-1F204D31-7580-4CE5-B852-489BB1C997AB

Q34603772-2B59726E-08AC-47F8-B82B-C1FA8FEF6F06

Q34603772-33B594C1-2D6B-4CF5-B178-6C4D6893E28A

Q34603772-3DE1A703-F108-4926-99C9-40E8BAAC6E3C

Q34603772-5496F7D0-ADA2-46CC-A73D-D12F1800130C

Q34603772-568C236B-B64D-41FF-9610-FB52655069FB

Q34603772-59E6D68D-737B-4E2F-9BAE-6083E29ADE3D

Q34603772-7127993E-2E56-4799-AC7A-996D62FF3CA7

Q34603772-723A8C3C-76D5-4CB7-8D70-39EA07DED3EC

P304

Q34603772-3D2ACBA8-4AE5-44AB-927A-A07CF13DEC40

P31

Q34603772-A1AE5322-988F-4418-8348-1A47767EDE8F

P356

Q34603772-FA9FFD47-3DCA-42E3-8CAA-E95209A2F501

P407

Q34603772-77BB7E06-9BF0-49B9-9446-CD8CAB5DB640

P433

Q34603772-7DDFE8BA-DD83-45E9-8E5D-C8BDD7DBF3CB

P478

Q34603772-BCA414E0-850D-479B-8A8D-4504CBC4ED50

P50

Q34603772-62A09E3C-DB9F-433B-9B1C-58D7164BAB7C

Q34603772-7916442F-1E0E-42BC-B72C-494932CCC450

Q34603772-7AC8CCED-50E2-4AD5-ACE7-4CDBE87EE372

Q34603772-D12ADF9A-BB91-4114-B220-43DB321E292C

P577

Q34603772-CC46B13D-DF63-4D53-8F05-E6CCE5565499

P5875

Q34603772-593F0BA1-D550-4450-BE6A-220240B32526

P698

Q34603772-88429125-96AA-4BEC-9F1C-97D9EE51AE51

P921

Q34603772-859FB346-7154-4A46-AE3B-FB9972D3E205

P932

Q34603772-DF084C1A-9806-42DB-BDAF-D5183ECA2E27

P356

P1433

Canadian Medical Association Journal

P1476

A population-based study of th ...... ump inhibitors and clopidogrel

@en

P2093

Alex Kopp

http://www.w3.org/2001/XMLSchema#string

David N Juurlink

http://www.w3.org/2001/XMLSchema#string

Muhammad M Mamdani

http://www.w3.org/2001/XMLSchema#string

Paul E Szmitko

http://www.w3.org/2001/XMLSchema#string

Tara Gomes

http://www.w3.org/2001/XMLSchema#string

P2860

Contribution of hepatic cytochrome P450 3A4 metabolic activity to the phenomenon of clopidogrel resistance

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

Outpatient gatifloxacin therapy and dysglycemia in older adults

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

A multicenter study of the coding accuracy of hospital discharge administrative data for patients admitted to cardiac care units in Ontario.

Comparison of coding of heart failure and comorbidities in administrative and clinical data for use in outcomes research.

Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study.

Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities.

Genetic determinants of response to clopidogrel and cardiovascular events.

Cytochrome p-450 polymorphisms and response to clopidogrel.

P304

713-718

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1503/CMAJ.082001

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

180

http://www.w3.org/2001/XMLSchema#string

P50

Peter C. Austin

P577

2009-01-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23956911

http://www.w3.org/2001/XMLSchema#string

P698

19176635

http://www.w3.org/2001/XMLSchema#string

P921

P932

2659819

http://www.w3.org/2001/XMLSchema#string